Stocks / NASDAQ / Spring Bank Pharmaceuticals, Inc.

Spring Bank Pharmaceuticals, Inc.

Our Opinion

Spring Bank Pharmaceuticals is on the Cruelty Free Investing list for exploiting animals because the company does animal testing in developing and commercialization of some of their therapeutics.

Supporting Evidence:

The company stated in the following article that they conduct pre-clinical trials of their drugs on animals.

“Animal Efficacy Studies in Chronically-Infected Woodchucks and Clinical Trial Results in Hepatitis C Patients Provide Support for Targeting RIG-I and NOD2 Sentinel Proteins to Restore Host Antiviral Defense.” Read the following article

Company Description

Spring Bank Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of a novel class of orally bioavailable therapeutics using proprietary Small Molecule Nucleic Acid Hybrid chemistry platform. Its pipeline SB 9200 HBV, deals with the treatment of Hepatitis B virus. [Source: MarketWatch]

Company Website: